Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Invega Sustenna
Invega Sustenna Image

Invega Sustenna

Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Invega Sustenna?

Invega Sustenna is an antipsychotic medication primarily prescribed for the treatment of schizophrenia in adult patients. This long-acting injection contains the active ingredient paliperidone palmitate, which is slowly released into the body over time. Schizophrenia is a chronic mental disorder characterized by distorted thoughts, delusions, hallucinations, and difficulties in thinking and communication. Invega Sustenna helps to alleviate these symptoms by affecting the levels of certain neurotransmitters in the brain, specifically dopamine and serotonin. The injection is typically administered once a month by a healthcare professional. It provides a sustained release of the medication, ensuring consistent therapeutic levels in the body. This can help with long-term symptom management and reduce the risk of relapse. It's important to note that Invega Sustenna may cause side effects, including drowsiness, weight gain, dizziness, and movement disorders. Patients should be closely monitored by their healthcare provider to ensure proper dosage and to address any potential side effects or interactions with other medications. As with any medication, it is crucial to follow the prescription guidelines and consult with a healthcare professional for personalized advice and monitoring throughout the treatment process.

How to use Invega Sustenna?

Invega Sustenna, also known as paliperidone palmitate, is an antipsychotic medication prescribed for the treatment of schizophrenia in adults. It is administered as a long-acting injectable medication, meaning it is given as an injection into the muscle and provides continuous release of the medication over an extended period of time. The dosage and frequency of Invega Sustenna injections will be determined by your healthcare provider based on your individual needs and response to the medication. Typically, the injections are given once every four weeks, although your doctor may adjust the dosing schedule if necessary. It is important to follow the instructions provided by your healthcare provider for the proper administration of Invega Sustenna. The injection is typically given in the deltoid muscle of the upper arm or the gluteal muscle in the buttocks. It should only be administered by a healthcare professional who is trained in the proper technique. Invega Sustenna should not be taken orally. It is important to continue taking this medication as prescribed, even if you start feeling better. Suddenly stopping the medication can lead to a recurrence of symptoms. If you have any questions or concerns about how to properly use Invega Sustenna, it is important to discuss them with your healthcare provider. They can provide you with detailed instructions and address any concerns you may have.

When using Invega Sustenna, there are several important warnings and precautions that you should be aware of. This medication, which is an antipsychotic used to treat schizophrenia in adults, may cause a range of side effects and have potential risks. One significant warning is the increased risk of mortality in elderly patients with dementia-related psychosis. Invega Sustenna is not approved for use in treating these conditions due to this increased risk. Additionally, there may be an increased risk of cerebrovascular events, such as strokes, associated with the use of this medication. Invega Sustenna may also cause a condition called neuroleptic malignant syndrome (NMS). This is a potentially life-threatening reaction that can occur with antipsychotic medications. Symptoms may include high fever, sweating, muscle stiffness, and changes in heart rate and blood pressure. Seek immediate medical attention if you experience these symptoms. Other warnings associated with Invega Sustenna include the potential for tardive dyskinesia, a movement disorder usually characterized by repetitive, involuntary movements of the face, tongue, or other body parts. This can be irreversible in some cases, and the risk may increase with long-term use of the medication. Invega Sustenna may also cause metabolic changes, such as weight gain, high blood sugar, and dyslipidemia (abnormal lipid levels). Regular monitoring of weight, blood sugar, and lipid levels is recommended while using this medication. It's essential to discuss any pre-existing medical conditions or medications you're taking with your healthcare provider before starting Invega Sustenna, as it may interact with other drugs or exacerbate existing conditions. As always, it is crucial to follow the instructions and guidance of your healthcare provider when prescribed Invega Sustenna to ensure safety and effectiveness in treating your condition.

Before taking Invega Sustenna, there are several important warnings and precautions that individuals should be aware of. Please note that this information is not exhaustive, and it's essential to consult with a healthcare professional for personalized advice. 1. Allergies: If you have a known allergy to paliperidone or any other ingredients in Invega Sustenna, inform your doctor. Allergic reactions can range from mild rashes to severe reactions that require immediate medical attention. 2. Elderly patients with dementia-related psychosis: Invega Sustenna is not approved for the treatment of elderly patients with dementia-related psychosis due to an increased risk of death. Elderly patients with this condition may experience cardiovascular or infectious complications. 3. Neuroleptic Malignant Syndrome (NMS): In rare cases, Invega Sustenna can cause NMS, a potentially life-threatening condition characterized by high fever, muscle stiffness, confusion, and other symptoms. This requires immediate medical attention. 4. Tardive Dyskinesia (TD): The use of antipsychotic medications like Invega Sustenna may increase the risk of developing TD, a movement disorder characterized by repetitive, involuntary movements of the face, tongue, or other body parts. The risk of TD is higher in older adults, especially women. Regular monitoring is necessary during treatment. 5. Metabolic changes: Invega Sustenna may lead to metabolic changes, such as increased blood sugar levels, weight gain, and lipid abnormalities. Regular monitoring of blood glucose, weight, and lipids is advised. 6. Cardiovascular effects: This medication may cause changes in heart rhythm, specifically prolongation of the QT interval. It's important to inform your healthcare provider if you have a history of heart problems or are taking medications that may affect the heart rhythm. 7. Pregnancy and breastfeeding: Invega Sustenna should only be used during pregnancy or breastfeeding if the potential benefits outweigh the risks. It's crucial to discuss this with your healthcare provider. 8. Other medications and medical conditions: Inform your doctor about all the medications (prescription, over-the-counter, herbal) you are taking, as well as any medical conditions you have. Some medications or conditions may interact with Invega Sustenna or increase the risk of side effects. It's important to have open and honest communication with your healthcare provider before starting Invega Sustenna to ensure its safe and effective use.

Invega Sustenna is an antipsychotic medication that is prescribed for the treatment of schizophrenia in adults. While it can be effective in managing the symptoms of this condition, it can also produce certain side effects. It is important to note that the occurrence and severity of side effects may vary from person to person. Common side effects of Invega Sustenna include weight gain, dizziness, drowsiness, headache, restlessness, nausea, and constipation. These side effects are generally mild and tend to improve over time as the body adjusts to the medication. In some cases, more serious side effects may occur. These can include movement disorders such as tremors, muscle stiffness, and uncontrollable body movements. Additionally, the medication may cause changes in blood sugar levels and lipid levels, which can increase the risk of developing diabetes or cardiovascular diseases. It is essential to monitor any unusual or severe side effects and report them to your healthcare provider. They will be able to assess your individual situation and determine the best course of action. It is also important to follow the prescribed dosage and attend regular check-ups to ensure the medication's effectiveness and monitor for any potential side effects.

Invega Sustenna is an antipsychotic medication indicated for the treatment of schizophrenia in adults. It is an extended-release injectable formulation that provides a sustained release of the active ingredient over a period of time. The active ingredient in Invega Sustenna is paliperidone palmitate. Paliperidone palmitate is an atypical antipsychotic drug that works by blocking certain neurotransmitters in the brain, including dopamine and serotonin. By modulating these neurotransmitters, Invega Sustenna helps to reduce the symptoms of schizophrenia such as hallucinations, delusions, and disorganized thinking. In addition to the active ingredient, paliperidone palmitate, Invega Sustenna also contains several other ingredients that help form the extended-release formulation. These include: 1. Polysorbate 20: This is a nonionic surfactant that helps with the dispersion of the medication. 2. Polyethylene glycol 4000: It acts as a binder and enhances the stability of the formulation. 3. Citric acid monohydrate: It is used as a pH adjuster to maintain the appropriate acidity or alkalinity. 4. Sodium hydroxide: It is used as a pH adjuster to maintain the appropriate acidity or alkalinity. 5. Sodium phosphate monobasic monohydrate: It acts as a buffering agent to maintain the stability of the formulation. 6. Sodium dihydrogen phosphate dihydrate: It acts as a buffering agent to maintain the stability of the formulation. These ingredients work together to ensure that the medication is released slowly and consistently into the bloodstream, providing a long-lasting effect and minimizing the need for frequent dosing. It is important to follow the prescribed dosing schedule and consult with a healthcare professional for proper administration of Invega Sustenna.

Invega Sustenna is an injectable antipsychotic medication used to treat schizophrenia in adults. When it comes to storage, it is important to follow the specific instructions provided by the manufacturer and your healthcare provider. Typically, Invega Sustenna should be stored in a refrigerator between 36°F and 46°F (2°C and 8°C). It is important to keep the medication in its original packaging and protect it from light. If you prefer to use a pre-filled syringe, you can store it at room temperature between 68°F and 77°F (20°C and 25°C) for up to 7 days. Make sure to keep it protected from light and discard any unused medication after this period. Never freeze Invega Sustenna or expose it to temperatures above 86°F (30°C). Additionally, avoid storing it in extreme humidity or leaving it in the bathroom. Always check the packaging or consult with your pharmacist for any specific storage requirements or concerns.